FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560146075> ?p ?o ?g. }

• W2560146075 endingPage "65" @default.
• W2560146075 startingPage "54" @default.
• W2560146075 abstract "Randomized controlled trials have concluded that the cardiovascular outcome of first-step treatment of hypertension with traditional vasoconstricting beta-blockers is inferior to treatment with other antihypertensive drug classes. Beta-blocker use is also associated with undesirable side effects. Consequently, some recent guidelines consider beta-blockers an inferior option for first-step treatment of hypertension. Despite this, beta-blockers are still widely prescribed, and likely overused, in the management of hypertension. It is the contention of this perspective that beta-blockers do have an important role in treating hypertension, but their use needs to be much better targeted, by better identification of both the right patient and the right beta-blocker. Identifying the right patient involves consideration of underlying mechanisms of hypertension. In the absence of comorbidities for which a beta-blocker is indicated, beta-blockers would not seem to be the preferred treatment for patients with either sodium/volume-mediated hypertension, for which they are usually ineffective, or for those with renin-angiotensin system-mediated hypertension, for which angiotensin-converting enzyme inhibitors and angiotensin receptor blockers provide equal antihypertensive efficacy with evidence of better outcome and fewer adverse effects. Beta-blockers would instead appear to be best suited for patients with sympathetically driven, that is, neurogenic, hypertension, whether as a first-step drug, such as in patients with hypertension in the acute post-stroke period, in so-called hyperkinetic patients, and in patients with labile hypertension, or as an add-on drug in patients with resistant hypertension. In choosing among the beta-blockers, combined alpha/beta-blockade offers advantages over beta-blocker monotherapy and merits greater clinical and research attention. Finally, unreliable bioavailability greatly interferes with the effectiveness of lipophilic, but not nonlipophilic, beta-blockers. Clinical effectiveness could be improved with greater focus on the beta-blockers with the more favorable pharmacokinetics." @default.
• W2560146075 created "2016-12-16" @default.
• W2560146075 creator A5004794575 @default.
• W2560146075 date "2017-01-01" @default.
• W2560146075 modified "2023-10-11" @default.
• W2560146075 title "Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient" @default.
• W2560146075 cites W121028365 @default.
• W2560146075 cites W1483141901 @default.
• W2560146075 cites W1485129821 @default.
• W2560146075 cites W1521358982 @default.
• W2560146075 cites W1523298739 @default.
• W2560146075 cites W1549915573 @default.
• W2560146075 cites W1736884335 @default.
• W2560146075 cites W1967308755 @default.
• W2560146075 cites W1967788840 @default.
• W2560146075 cites W1969506301 @default.
• W2560146075 cites W1971826253 @default.
• W2560146075 cites W1975883136 @default.
• W2560146075 cites W1977607782 @default.
• W2560146075 cites W1978190600 @default.
• W2560146075 cites W1984366579 @default.
• W2560146075 cites W1985993311 @default.
• W2560146075 cites W1986014563 @default.
• W2560146075 cites W1989044988 @default.
• W2560146075 cites W1991118170 @default.
• W2560146075 cites W1991929019 @default.
• W2560146075 cites W1996051168 @default.
• W2560146075 cites W1996667713 @default.
• W2560146075 cites W1996737406 @default.
• W2560146075 cites W1996992752 @default.
• W2560146075 cites W2001861423 @default.
• W2560146075 cites W2002192189 @default.
• W2560146075 cites W2002982077 @default.
• W2560146075 cites W2013016047 @default.
• W2560146075 cites W2016891737 @default.
• W2560146075 cites W2017365566 @default.
• W2560146075 cites W2021334280 @default.
• W2560146075 cites W2021482008 @default.
• W2560146075 cites W2021721280 @default.
• W2560146075 cites W2022419872 @default.
• W2560146075 cites W2023905894 @default.
• W2560146075 cites W2024867919 @default.
• W2560146075 cites W2024956494 @default.
• W2560146075 cites W2027171416 @default.
• W2560146075 cites W2029436713 @default.
• W2560146075 cites W2029721531 @default.
• W2560146075 cites W2031376707 @default.
• W2560146075 cites W2035771450 @default.
• W2560146075 cites W2036572057 @default.
• W2560146075 cites W2038359925 @default.
• W2560146075 cites W2040748240 @default.
• W2560146075 cites W2049683035 @default.
• W2560146075 cites W2053816472 @default.
• W2560146075 cites W2054797196 @default.
• W2560146075 cites W2061984844 @default.
• W2560146075 cites W2065593854 @default.
• W2560146075 cites W206590124 @default.
• W2560146075 cites W2066617347 @default.
• W2560146075 cites W2067015350 @default.
• W2560146075 cites W2069357664 @default.
• W2560146075 cites W2072785882 @default.
• W2560146075 cites W2073805707 @default.
• W2560146075 cites W2076245717 @default.
• W2560146075 cites W2082111734 @default.
• W2560146075 cites W2082758698 @default.
• W2560146075 cites W2084076051 @default.
• W2560146075 cites W2088581697 @default.
• W2560146075 cites W2098591026 @default.
• W2560146075 cites W2099181900 @default.
• W2560146075 cites W2099567527 @default.
• W2560146075 cites W2103256591 @default.
• W2560146075 cites W2104228024 @default.
• W2560146075 cites W2114333967 @default.
• W2560146075 cites W2114369401 @default.
• W2560146075 cites W2116224448 @default.
• W2560146075 cites W2117529378 @default.
• W2560146075 cites W2122468991 @default.
• W2560146075 cites W2126125759 @default.
• W2560146075 cites W2130234373 @default.
• W2560146075 cites W2137371365 @default.
• W2560146075 cites W2139692142 @default.
• W2560146075 cites W2141078753 @default.
• W2560146075 cites W2142692525 @default.
• W2560146075 cites W2143400105 @default.
• W2560146075 cites W2149747907 @default.
• W2560146075 cites W2151003504 @default.
• W2560146075 cites W2151273903 @default.
• W2560146075 cites W2152660527 @default.
• W2560146075 cites W2156971784 @default.
• W2560146075 cites W2159432173 @default.
• W2560146075 cites W2168553362 @default.
• W2560146075 cites W2170828534 @default.
• W2560146075 cites W2297753288 @default.
• W2560146075 cites W2337176310 @default.
• W2560146075 cites W2341712066 @default.
• W2560146075 cites W2412251445 @default.
• W2560146075 cites W2415991484 @default.
• W2560146075 cites W74300047 @default.

• next